You are here
- Home
- Total number of clinical trials
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Malignancies
- Disease
- cancer
- Drug Name
- AZD4547
- Generic Name
- AZD4547
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Oct 20, 2009
- Study Name
- D2610C00001
- Study Id
- D2610C00001
- ClinicalTrials.gov ID
- NCT00979134
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
